Literature DB >> 9010235

Further characterisation of the p53 responsive element--identification of new candidate genes for trans-activation by p53.

J C Bourdon1, V Deguin-Chambon, J C Lelong, P Dessen, P May, B Debuire, E May.   

Abstract

The p53 protein is known to trans-activate a number of genes by specific binding to a consensus sequence containing two decamers of the type: PuPuPuCA/TT/AGPyPyPy. In order to identify new p53 trans-activated genes, we defined a set of criteria for computer search of p53-responsive elements. Based on experimental data, we proposed an extended consensus sequence composed of the two decamers of the El-Deiry consensus sequence flanked by two additional ones. A maximum of 3 bp substitutions was accepted for the two decamers of the El-Deiry consensus sequence, as well as for each additional decamer, except when the two decamers of the El-Deiry consensus sequence are contiguous. In this case, each additional decamer is allowed to bear one base insertion or deletion between the median C and G. This set of criteria was validated by identifying within the promoter region of the IGF-BP3 gene the existence of a novel p53-responsive element whose functional significance was verified. By limiting our computer search to Vertebrate genes involved in cell cycle regulation, cellular adhesion or metastatic processes and to gene families most often found in HOVERGEN database, 7785 gene sequences were first analysed. Among the oncogenes, kinases, proteases and structural proteins, 55 new genes were selected; six of them were retrieved in more than one species.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010235     DOI: 10.1038/sj.onc.1200804

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  Apoptosis regulation in tetraploid cancer cells.

Authors:  Maria Castedo; Arnaud Coquelle; Sonia Vivet; Ilio Vitale; Audrey Kauffmann; Philippe Dessen; Marie O Pequignot; Noelia Casares; Alexandre Valent; Shahul Mouhamad; Elise Schmitt; Nazanine Modjtahedi; William Vainchenker; Laurence Zitvogel; Vladimir Lazar; Carmen Garrido; Guido Kroemer
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

2.  The C terminus of p53 family proteins is a cell fate determinant.

Authors:  Kelly Lynn Harms; Xinbin Chen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  p53 Dynamically Directs TFIID Assembly on Target Gene Promoters.

Authors:  R A Coleman; Z Qiao; S K Singh; C S Peng; M Cianfrocco; Z Zhang; A Piasecka; H Aldeborgh; G Basishvili; W L Liu
Journal:  Mol Cell Biol       Date:  2017-06-15       Impact factor: 4.272

4.  p53 directly transactivates Δ133p53α, regulating cell fate outcome in response to DNA damage.

Authors:  M Aoubala; F Murray-Zmijewski; M P Khoury; K Fernandes; S Perrier; H Bernard; A-C Prats; D P Lane; J-C Bourdon
Journal:  Cell Death Differ       Date:  2010-08-06       Impact factor: 15.828

5.  EGF-mediated regulation of IGFBP-3 determines esophageal epithelial cellular response to IGF-I.

Authors:  Munenori Takaoka; Caitlin E Smith; Michael K Mashiba; Takaomi Okawa; Claudia D Andl; Wafik S El-Deiry; Hiroshi Nakagawa
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-10-06       Impact factor: 4.052

6.  p53-Dependent and p53-independent induction of insulin-like growth factor binding protein-3 by deoxyribonucleic acid damage and hypoxia.

Authors:  Adda Grimberg; Carrie M Coleman; Timothy F Burns; Bruce P Himelstein; Cameron J Koch; Pinchas Cohen; Wafik S El-Deiry
Journal:  J Clin Endocrinol Metab       Date:  2005-03-15       Impact factor: 5.958

7.  Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.

Authors:  Heejei Yoon; Sandya Liyanarachchi; Fred A Wright; Ramana Davuluri; Janet C Lockman; Albert de la Chapelle; Natalia S Pellegata
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

8.  The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor.

Authors:  A Elkeles; T Juven-Gershon; D Israeli; S Wilder; A Zalcenstein; M Oren
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

Review 9.  p53 Family isoforms.

Authors:  Jean-Christophe Bourdon
Journal:  Curr Pharm Biotechnol       Date:  2007-12       Impact factor: 2.837

10.  Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinoma.

Authors:  Pao-Ling Torng; Ching-Wei Lin; Michael Wy Chan; Hui-Wen Yang; Su-Cheng Huang; Chin-Tarng Lin
Journal:  Mol Cancer       Date:  2009-12-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.